 |
print the page |  |
email the page |  |
|
- What is Alzheimer's disease?
- Symptoms of Alzheimer's disease
- Causes of Alzheimer's disease
- Prevention of Alzheimer's disease
- Risk factors for Alzheimer's disease
- Complications of Alzheimer's disease
- When to see a doctor about Alzheimer's disease
- Diagnosis of Alzheimer's disease
- Conventional treatment of Alzheimer's disease
- Alternative/complementary treatment of Alzheimer's disease
- Living with Alzheimer's disease
- Caring for someone with Alzheimer's disease
Advertisement
Advertisement
Sections: 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12
Last reviewed: 7 October 2007 || Last updated: 12 March 2009
Related Articles
references
- Bai DL, Tang XC, He XC. Huperzine A, a potential therapeutic agent for treatment of Alzheimer's disease. Curr Med Chem. 2000 Mar;7(3):355-74
- Desilets AR, Gickas JJ, Dunican KC. Role of Huperzine A in the Treatment of Alzheimer's Disease. Ann Pharmacother. 2009 Feb 24
- Dos Santos-Neto LL, de Vilhena Toledo MA, Medeiros-Souza P, de Souza GA. The use of herbal medicine in Alzheimer's disease. Evid Based Complement Alternat Med. 2006 Dec;3(4):441-5. Epub 2006 Oct 23
- Engelhart MJ, et al. Plasma Levels of Antioxidants Are Not Associated with Alzheimer's Disease or Cognitive Decline. Dementia 2005; 19: 2-3
- Haan MN, Wallace R. Can dementia be prevented? Brain aging in a population-based context. Annu Rev Public Health. 2004;25:1-24
- Kelley BJ, Knopman DS. Alternative medicine and Alzheimer disease. Neurologist. 2008 Sep;14(5):299-306
- Kerksick C, Willoughby D. The antioxidant role of glutathione and N-acetyl-cysteine supplements and exercise-induced oxidative stress. J Int Soc Sports Nutr. 2005 Dec 9;2:38-44
- Li J, Wu HM, Zhou RL, Liu GJ, Dong BR. Huperzine A for Alzheimer's disease. Cochrane Database Syst Rev. 2008 Apr 16;(2):CD005592
- Little JT, Walsh S, Aisen PS. An update on huperzine A as a treatment for Alzheimer's disease. Expert Opin Investig Drugs. 2008 Feb;17(2):209-15
- Mulder C, Wahlund LO, Teerlink T, Blomberg M, Veerhuis R, van Kamp GJ, Scheltens P, Scheffer PG. Decreased lysophosphatidylcholine/phosphatidylcholine ratio in cerebrospinal fluid in Alzheimer's disease. J Neural Transm. 2003 Aug;110(8):949-55
- Osieki H. The Physicians Handbook of Clinical Nutrition. BioConcepts Publishing, 6th Edition, 2001
- Parnetti L, Mignini F, Tomassoni D, Traini E, Amenta F. Cholinergic precursors in the treatment of cognitive impairment of vascular origin: ineffective approaches or need for re-evaluation? J Neurol Sci. 2007 Jun 15;257(1-2):264-9
- Ribes D, Colomina MT, Vicens P, Domingo JL. Effects of oral aluminum exposure on behavior and neurogenesis in a transgenic mouse model of Alzheimer's disease. Exp Neurol. 2008 Dec;214(2):293-300
- Rodella LF, Ricci F, Borsani E, et al. Aluminium exposure induces Alzheimer's disease-like histopathological alterations in mouse brain. Histol Histopathol. 2008 Apr;23(4):433-9
- Rondeau V, Jacqmin-Gadda H, Commenges D, Helmer C, Dartigues JF. Aluminum and silica in drinking water and the risk of Alzheimer's disease or cognitive decline: findings from 15-year follow-up of the PAQUID cohort. Am J Epidemiol. 2009 Feb 15;169(4):489-96
- Schaefer EJ, Bongard V, Beiser AS, Lamon-Fava S, Robins SJ, Au R, Tucker KL, Kyle DJ, Wilson PW, Wolf PA. Plasma phosphatidylcholine docosahexaenoic acid content and risk of dementia and Alzheimer disease: the Framingham Heart Study. Arch Neurol. 2006 Nov;63(11):1545-50
- Solomon PR, Adams F, Silver A, Zimmer J, DeVeaux R. Ginkgo for memory enhancement: a randomized controlled trial. Journal of the American Medical Association. 2002;288(7):835-840
- Stephan BC, Brayne C. Vascular factors and prevention of dementia. Int Rev Psychiatry. 2008 Aug;20(4):344-56
- Tratter R, Jones A. Better Health Through Natural Healing: How to Get Well Without Drugs or Surgery, 2nd Edition. McGraw Hill, 2001
- Troen AM, Shea-Budgell M, Shukitt-Hale B, Smith DE, Selhub J, Rosenberg IH. B-vitamin deficiency causes hyperhomocysteinemia and vascular cognitive impairment in mice. Proc Natl Acad Sci U S A. 2008 Aug 26;105(34):12474-9
- Ved HS, Koenig ML, Dave JR, Doctor BP. Huperzine A, a potential therapeutic agent for dementia, reduces neuronal cell death caused by glutamate. Neuroreport. 1997 Mar 3;8(4):963-8
- Zandi PP, et. al. Reduced Risk of Alzheimer Disease in Users of Antioxidant Vitamin Supplements (Arch Neurol 2004; 61:82-88)
- Zhang HY, Tang XC. Neuroprotective effects of huperzine A: new therapeutic targets for neurodegenerative disease. Trends Pharmacol Sci. 2006 Dec;27(12):619-25. Epub 2006 Oct 23
- Zhang HY, Yan H, Tang XC. Non-cholinergic effects of huperzine A: beyond inhibition of acetylcholinesterase. Cell Mol Neurobiol. 2008 Feb;28(2):173-83
- Zhang Q, Yang G, Li W, Fan Z, Sun A, Luo J, Ke ZJ. Thiamine deficiency increases beta-secretase activity and accumulation of beta-amyloid peptides. Neurobiol Aging. 2009 Feb 20
To learn more, go to the following web sites:
- Alzheimer's Australia (Australia)
- Alzheimer's Disease International (UK)
- Alzheimer's Society (Canada)
- Alzheimer's Association (USA)
- National Institute on Aging (USA)
NOTE: Mega doses of any type of vitamin, mineral, amino acid or herbal supplement cannot cure illnesses and in fact can be very dangerous and produce toxic side effects and interfere with medicine you are taking. Always ensure you consult your doctor before taking any type of complementary supplements.
Disclaimer: This guide is not intended to be used for diagnostic or prescriptive purposes. For any treatment or diagnosis of illness, please see your doctor.
